Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Cardiovascular Disease Risk in End-Stage Renal Disease

Plasma leucine-Rich α-2-glycoprotein 1 (LRG1) is an innovative biomarker for inflammation and angiogenesis. Many adverse pathophysiological changes including inflammation, atherosclerosis, and premature mortality is associated with End-stage renal disease (ESRD). However, whether levels of plasma LR...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Feng-Jung, Hsieh, Chun-Yih, Shu, Kai-Hsiang, Chen, I-Yu, Pan, Szu-Yu, Chuang, Yi-Fang, Chiu, Yen-Ling, Yang, Wei-Shiung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136266/
https://www.ncbi.nlm.nih.gov/pubmed/32249825
http://dx.doi.org/10.1038/s41598-020-62989-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136266/
https://www.ncbi.nlm.nih.gov/pubmed/32249825
http://dx.doi.org/10.1038/s41598-020-62989-7

Ejemplares similares